Early Assessment of Teplizumab Treatment Response Using Continuous Glucose Monitoring [0.03%]
使用连续葡萄糖监测进行Teplizumab治疗反应的早期评估
Sari Krepel-Volsky,Merav Gil-Margolis,Keren Smuel-Zilberberg et al.
Sari Krepel-Volsky et al.
We describe continuous glucose monitoring (CGM) trajectories in five children with stage 2 type 1 diabetes treated with teplizumab in a real-world setting. Participants were followed longitudinally using CGM metrics, including glycemic vari...
Kimia Z Assadi,Edwin W D&#x;Souza,Jordan E Pinsker et al.
Kimia Z Assadi et al.
Background: Control-IQ+ technology (Control-IQ+) is available to Tandem t:slim X2 and Tandem Mobi insulin pump users in the United States. This algorithm update enhances support for individuals with a broader range of ins...
Glycemic Responses to Two Different Exercise Modalities in Adolescents with Type 1 Diabetes Using Automated Insulin Delivery Systems: The AIDing Exercise Study [0.03%]
使用自动胰岛素递送系统的一型糖尿病青少年两种不同运动方式的血糖反应：AIDing Exercise研究
Emilie B Lindkvist,Olivia M McCarthy,Sandra Tawfik et al.
Emilie B Lindkvist et al.
Objective: To examine the glycemic responses to two exercise modalities-high-intensity interval exercise (HIIE) and moderate-intensity continuous exercise (MICE)-when applying consensus guideline preexercise preparatory m...
Temporary Target Use with Automated Insulin Delivery Is Associated with Longer and Safer Exercise in Adolescents with Type 1 Diabetes: A Post Hoc Analysis from the Fast Advanced Closed-Loop Therapy Study [0.03%]
临时目标范围结合自动化胰岛素输注可使1型糖尿病青少年更安全、更长时间地运动：来自快速先进闭环治疗研究的事后分析
Dessi P Zaharieva,Simon Bergford,Natasa Bratina et al.
Dessi P Zaharieva et al.
This post hoc analysis of the Fast Advanced Closed-Loop Therapy study investigated associations between temporary target (TempT) use and exercise-related glycemia. Youth with type 1 diabetes (T1D) used automated insulin delivery with two in...
Adjunctive Treatment with GLP-1 and Dual GLP-1/GIP Receptor Agonists for People with Type 1 Diabetes: Consensus Report and Practical Guidelines for Safe Use [0.03%]
GLP-1及GLP-1/GIP受体激动剂作为1型糖尿病辅助治疗的专家共识及安全使用指导意见
Satish K Garg,Halis K Akturk,Samita Garg et al.
Satish K Garg et al.
Among the most impactful therapeutic advances in the management of diabetes over the past two decades has been the development of incretin-based therapies, specifically glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) and in combinat...
Continuous Glucose Monitoring in Pregnant Women with Type 1 Diabetes: Outcomes of a Population-Based Real-World Study [0.03%]
连续葡萄糖监测在1型糖尿病孕妇中的应用：一项基于人口的真实世界研究结果
Sarah A L Price,Melissa Chee,Arul Earnest et al.
Sarah A L Price et al.
Background: Continuous glucose monitoring (CGM) is increasingly used by women with type 1 diabetes (T1D) during pregnancy, but there are limited data on glycemic and pregnancy outcomes in large real-world cohorts. ...
Increased Glycation Ratio and Risk of Complications in Latent Autoimmune Diabetes in Adults Compared With Type 1 Diabetes Onset before 30 Years: A Cohort Study [0.03%]
成人隐匿性自身免疫糖尿病患者焦糖化比率升高及与30岁前起病的1型糖尿病并发症风险的关系：队列研究
Sandra Herranz-Antolín,Fernando Gómez-Peralta,Xu Yongjin et al.
Sandra Herranz-Antolín et al.
Objective: To clarify the distinctions between Latent Autoimmune Diabetes in Adults (LADA) and Type 1 diabetes (T1D) diagnosed < 30 years using continuous glucose monitoring (CGM) metrics, glycation rate, and risk of comp...
Todd L Burstain,Irl B Hirsch,Roy W Beck
Todd L Burstain
Raising the Bar: High Time in Range During the First Year of Diagnosis of Type 1 Diabetes in Children and Adolescents Using Automated Insulin Delivery with Intense Support [0.03%]
提质增效：在儿童及青少年1型糖尿病诊断第一年内使用自动化胰岛素输送结合高强度支持提高血糖控制达标时间的比例
Michelle Van Name,Jennifer Sherr,Colleen Bauza et al.
Michelle Van Name et al.
Glycemic Concordance of Simplera Sync ™ and Instinct ™ Sensors in MiniMed ™ 780G System Users: A Randomized Crossover Feasibility Study [0.03%]
Simplera Sync™和Instinct™传感器在MiniMed™ 780G系统用户中的血糖一致性：一项随机交叉可行性研究
Maya Laron-Hirsh,Sapir Barel,Anirban Roy et al.
Maya Laron-Hirsh et al.
Introduction: This study evaluated the performance of Simplera Sync™ and Instinct™ sensors when paired with the MiniMed™ 780G (MM780G) system and assessed whether switching between sensors affected clinical outcomes of people with type 1...